↓ Skip to main content

Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib®versus TACE plus placebo in patients with…

Overview of attention for article published in BMC Cancer, November 2008
Altmetric Badge

Readers on

mendeley
68 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib®versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation – HeiLivCa [ISRCTN24081794]
Published in
BMC Cancer, November 2008
DOI 10.1186/1471-2407-8-349
Pubmed ID
Authors

K Hoffmann, H Glimm, B Radeleff, G Richter, C Heining, I Schenkel, A Zahlten-Hinguranage, P Schirrmacher, J Schmidt, MW Büchler, D Jaeger, C von Kalle, P Schemmer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 3%
France 1 1%
Unknown 65 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 22%
Other 7 10%
Student > Ph. D. Student 6 9%
Student > Postgraduate 5 7%
Professor > Associate Professor 5 7%
Other 17 25%
Unknown 13 19%
Readers by discipline Count As %
Medicine and Dentistry 40 59%
Agricultural and Biological Sciences 4 6%
Biochemistry, Genetics and Molecular Biology 2 3%
Nursing and Health Professions 2 3%
Neuroscience 2 3%
Other 3 4%
Unknown 15 22%